Research Article
A Circulating Long Noncoding RNA Panel Serves as a Diagnostic Marker for Hepatocellular Carcinoma
Table 3
Correlation between serum level of lncRNAs HULC, MALAT1, and Linc00152 and clinicopathological characteristics in 129 HCC patients.
| Features | HULC | MALAT1 | Linc00152 | Low () | High () | | Low () | High () | | Low () | High () | |
| Gender | | | 0.327 | | | 0.327 | | | 0.636 | Male | 54 | 57 | | 54 | 57 | | 55 | 56 | | Female | 11 | 7 | | 11 | 7 | | 10 | 8 | | Age | | | 0.333 | | | 0.333 | | | 0.801 | ≤55 | 24 | 29 | | 24 | 29 | | 26 | 27 | | >55 | 41 | 35 | | 41 | 35 | | 39 | 37 | | HBsAg | | | 0.270 | | | 0.314 | | | 0.796 | Positive | 53 | 47 | | 48 | 52 | | 51 | 49 | | Negative | 12 | 17 | | 17 | 12 | | 14 | 15 | | AFP level | | | 0.781 | | | 0.323 | | | 0.127 | ≤20 ng/mL | 29 | 27 | | 31 | 25 | | 33 | 41 | | >20 ng/mL | 36 | 37 | | 34 | 39 | | 32 | 23 | | Tumor size | | | 0.897 | | | 0.530 | | | 0.315 | ≤3 cm | 21 | 20 | | 19 | 22 | | 18 | 23 | | >3 cm | 44 | 44 | | 46 | 42 | | 47 | 41 | | Tumor number | | | 0.611 | | | 0.668 | | | 0.611 | Single | 55 | 52 | | 53 | 54 | | 55 | 52 | | Multiple | 10 | 12 | | 12 | 10 | | 10 | 12 | | GGT (U/L) | 80 (14-2000) | 77 (13-1034) | 0.944 | 80 (13-2000) | 84 (14-1034) | 0.265 | 61 (13-697) | 98 (15-2000) | 0.012 | ALT (U/L) | 40 (7-451) | 37 (12-1198) | 0.944 | 37 (7-621) | 37.5 (12-1198) | 0.929 | 34 (7-668) | 40 (12-1198) | 0.378 | AST (U/L) | 47 (17-577) | 41 (17-1474) | 0.901 | 38 (18-577) | 51 (17-1474) | 0.142 | 36 (17-577) | 48 (17-1474) | 0.077 | TP (g/L) | 69.5 (56.0-80.6) | 68.3 (43.4-84.8) | 0.376 | 68.8 (55.3-84.8) | 68.3 (43.4-84.2) | 0.232 | 68.4 (46.8-79) | 68.7 (43.4-84.8) | 0.644 | ALB (g/L) | 40.3 (23.9-48.9) | 39.3 (21.4-48.6) | 0.564 | 40.3 (23.8-48.9) | 39.2 (21.4-47.7) | 0.170 | 40.0 (23.9-47.2) | 40.2 (21.4-48.9) | 0.888 |
|
|
. AFP: alpha fetoprotein; GGT: gamma-glutamyl transpeptidase; ALT: alanine aminotransferase; AST: aspartic transaminase; TP: total protein; ALB: albumin. |